Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$40.46 USD
-0.71 (-1.72%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $40.46 0.00 (0.00%) 7:48 PM ET
4-Sell of 5 4
D Value C Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$40.46 USD
-0.71 (-1.72%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $40.46 0.00 (0.00%) 7:48 PM ET
4-Sell of 5 4
D Value C Growth A Momentum C VGM
Zacks News
The Saga to Revoke Obamacare Continues: 3 MedTech Picks
by Zacks Equity Research
In the wake of the turbulent political scenario and banking on favorable metrics, these three MedTech stocks stand out as the most suitable picks.
Implied Volatility Surging for Tandem (TNDM) Stock Options
by Zacks Equity Research
Tandem (TNDM) warrants investors' attention based on moves in the options market lately.
3 Med-Instrument Stocks Poised to Gain this Earnings Season
by Zacks Equity Research
2015 is forecasted to be a transition year for the medical instruments sector.